Received Sep 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
she has a cold; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (she has a cold) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (she has a cold). At the time of the report, NASOPHARYNGITIS (she has a cold) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. Concomitant medication was not provided. It was reported that the patient had scheduled a Covid 19 vaccine on that day. However, she had a cold and wanted to know if she should postpone it. It was also reported that the patient had received other Covid 19 vaccines in the past. It was unknown if the patient experienced any additional symptoms or events. Treatment medication was not reported.